UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$948M |
| 2 |
Snowflake
SNOW
|
+$542M |
| 3 |
Sea Limited
SE
|
+$501M |
| 4 |
Procter & Gamble
PG
|
+$491M |
| 5 |
Snap
SNAP
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$434M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$350M |
| 3 |
Lowe's Companies
LOW
|
+$215M |
| 4 |
Applied Materials
AMAT
|
+$186M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.21% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 12.28% |
| 5 | Communication Services | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
The GEO Group
GEO
$4.04B
| $1.25M | ﹤0.01% |
167,407
+19,198
| +13% | +$141K |
|
2002
National Beverage
FIZZ
$3.01B
| $1.25M | ﹤0.01% |
23,737
+5,919
| +33% | +$275K |
|
2003
FB Financial Corp
FBK
$3.04B
| $1.24M | ﹤0.01% |
28,963
| – | – |
|
2004
Angi Inc
ANGI
$196M
| $1.24M | ﹤0.01% |
10,028
-1,050
| -9% | -$121K |
|
2005
Anavex Life Sciences
AVXL
$310M
| $1.23M | ﹤0.01% |
68,751
+567
| +0.8% | +$11.3K |
|
2006
RadNet
RDNT
$5.69B
| $1.23M | ﹤0.01% |
42,013
+530
| +1% | +$17K |
|
2007
Dime Commercial Bancshares
DCOM
$1.78B
| $1.23M | ﹤0.01% |
37,599
| – | – |
|
2008
Usana Health Sciences
USNA
$286M
| $1.22M | ﹤0.01% |
13,284
+3,017
| +29% | +$290K |
|
|
CWEN.A
2009
DELISTED
Clearway Energy Class A
CWEN.A
| $1.22M | ﹤0.01% |
43,413
| – | – |
|
2010
HCI Group
HCI
$2.41B
| $1.22M | ﹤0.01% |
11,026
-1,233
| -10% | -$129K |
|
|
CDMO
2011
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.22M | ﹤0.01% |
56,619
+6,218
| +12% | +$150K |
|
|
KUKE
2012
DELISTED
Kuke Music
KUKE
| $1.22M | ﹤0.01% |
20,110
-7,360
| -27% | -$438K |
|
|
BRMK
2013
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $1.21M | ﹤0.01% |
122,901
+1,476
| +1% | +$15.3K |
|
|
EB
2014
DELISTED
Eventbrite
EB
| $1.21M | ﹤0.01% |
63,945
+2,591
| +4% | +$45.5K |
|
2015
Quince Therapeutics
QNCX
$29.5M
| $1.21M | ﹤0.01% |
66
+1
| +2% | +$15.9K |
|
2016
Varex Imaging
VREX
$523M
| $1.21M | ﹤0.01% |
42,835
+8,772
| +26% | +$243K |
|
2017
Supernus Pharmaceuticals
SUPN
$2.77B
| $1.21M | ﹤0.01% |
45,285
| – | – |
|
2018
City Holding Co
CHCO
$2.04B
| $1.21M | ﹤0.01% |
15,486
-1,616
| -9% | -$123K |
|
2019
iShares MSCI Poland ETF
EPOL
$818M
| $1.2M | ﹤0.01% |
54,868
-14,471
| -21% | -$320K |
|
|
TVTY
2020
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.2M | ﹤0.01% |
52,070
+11,277
| +28% | +$268K |
|
2021
Benchmark Electronics
BHE
$2.96B
| $1.2M | ﹤0.01% |
44,888
+8,169
| +22% | +$217K |
|
|
NTUS
2022
DELISTED
Natus Medical Inc
NTUS
| $1.2M | ﹤0.01% |
47,701
+6,954
| +17% | +$177K |
|
2023
Porch Group
PRCH
$1.8B
| $1.2M | ﹤0.01% |
67,618
+8,094
| +14% | +$152K |
|
2024
Ubiquiti
UI
$34.3B
| $1.2M | ﹤0.01% |
4,002
| – | – |
|
|
CCXI
2025
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.19M | ﹤0.01% |
69,832
-23,233
| -25% | -$362K |
|
Similar funds
UBS AM's Q3 2021 Portfolio in Review
As of Q3 2021, UBS AM held 2,809 positions worth $241B, up 3.2% from $234B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM deployed $8.13B of net new capital in Q3 2021, opening 56 new positions and adding to 1,358 existing holdings. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Infosys, an estimated $434M trimmed.
- UBS AM's largest Q3 2021 buy was State Street SPDR Portfolio Intermediate Term Treasury ETF: 6,053,315 shares worth $196M.
- UBS AM added most to Microsoft in Q3 2021, an estimated $948M increase.
- UBS AM's biggest Q3 2021 reduction was Infosys, cutting an estimated $434M.
- UBS AM fully exited Vanguard Short-Term Treasury ETF in Q3 2021, selling an estimated $350M.
- UBS AM's ten largest holdings make up 22% of its $241B portfolio in Q3 2021.
- UBS AM opened 56 new positions and closed 62 in Q3 2021.
- UBS AM's portfolio value rose 3.2% quarter-over-quarter to $241B.
Based on UBS AM's 13F filing for Q3 2021, filed 15 Nov 2021.